, a provider of clinical research to drug developers, for more than $7 billion, including debt, people familiar with the matter said.
The sources said the deal could be announced as early as Wednesday and requested anonymity because the matter is confidential. Syneos, which carries a debt pile of nearly $3 billion, was created in 2017 by INC Research Holdings Inc's acquisition of inVentiv Health Inc for $7.4 billion, including debt.
Italia Ultime Notizie, Italia Notizie
Similar News:Puoi anche leggere notizie simili a questa che abbiamo raccolto da altre fonti di notizie.
Investment consortium nears deal for Syneos Health -sourcesA consortium comprising Elliott Investment Management, Patient Square Capital and Veritas Capital is nearing a deal to acquire Syneos Health Inc , a provider of clinical research to drug developers with a market value of $4 billion, people familiar with the matter said.
Leggi di più »
US weighs restrictions on investment in Chinese AI firmsThe U.S. government is planning an outbound investment screening mechanism that would potentially review overseas investments in sensitive technologies, including Chinese AI firms.
Leggi di più »
Sen. Ossoff, EPA leadership announce $4 billion investment in clean energy at US portsU.S. environmental leaders joined Sen Jon Ossoff in Savannah Friday afternoon to announce a historic $4 billion investment in clean energy infrastructure at U.S. ports and in the logistics industry.
Leggi di più »